Large-scale production of human-identical glycosphingolipids and gangliosides.
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Series C Portuguese biotech CarboCode raised a EUR 15M Series C led by Iberis Capital to scale production of breast-milk-identical nutritional compounds. | $15.9M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.